Oligonucleotide Synthesis Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Oligonucleotide Synthesis Market has been segmented by Product Type, Application (Research, Therapeutics, and Diagnostics), End-User and Geography.

Market Snapshot

oligonucleotide synthesis market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 12.3 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The oligonucleotide synthesis market is expected to register a CAGR of 12.3% during the forecast period. The growth of the oligonucleotide synthesis market is due to the increasing government investments and R&D expenditure in pharmaceutical and biotechnology companies and the use of synthesized oligonucleotides in molecular diagnostics and clinical applications.

  • The usage of synthetic oligonucleotides has been increasing rapidly over the past decade, owing to several benefits offered by molecular diagnostics and growing clinical applications. The nucleic acid application techniques are the reference methods, and they are very useful for carrying out the molecular diagnosis in several diseases, like for the detection of infectious diseases, such as hepatitis.
  • Synthetic oligonucleotides also have significant clinical applications, primarily for the detection of autoimmune antibodies. There have been consistent developments in synthetic biology over the past few years, where synthetic oligonucleotides were used to develop assays for the detection of anti-double-stranded DNAs. Thus, all these factors are responsible for the growth of the oligonucleotide synthesis market.
  • In addition, there are also other major factors influencing the market for oligonucleotide synthesis. These include the increasing advancement in the field of healthcare, increasing demand for innovation in the field of life science and medical academics, increasing investments by the government for the development of genomic technologies, and the increasing demand for oligonucleotide synthesis technologies by the public and private research firms.

Scope of the Report

As per the scope of the report, oligonucleotide synthesis is the chemical synthesis of relatively short fragments of nucleic acids with a defined chemical structure (sequence). The oligonucleotide synthesis market is segmented by product type, application, end-user and geography.

By Product Type
Synthesized Oligonucleotide Products
Reagents
Equipment
Services
By Application
Research
Diagnostics
Therapeutics
By End User
Academic Research Institutes
Pharmaceutical and Biotechnology Companies
Hospital and Diagnostic Laboratories
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Probes Segment is Expected to Grow during the Forecast Period

Oligonucleotide probes are short stretches of single-stranded DNA or RNA, primarily used to detect the presence of complementary nucleic acid sequences (target sequences) by hybridization.

They have wide applications in the life sciences industry. They are frequently used in the polymerization chain reaction (PCR) technique. In the real-time PCR technique, the DNA amount, if increased, can be observed and detected directly in real-time. This direct observation for quantification has raised new applications, particularly in diagnostics and validation, and is attained by using fluorescent dyes.

There are several types of probes, such as dual-labeled probes, double-quenched probes, fret probes, gene probes, etc. All of them have almost similar functions but are used for different applications.

oligonucelotide latest.png

North America is the Largest Growing Segment and is Expected to Follow the Same Trend Over the Forecast Period

North America dominates the market due to the presence of better healthcare infrastructure and the increasing usage of oligonucleotides by pharmaceutical companies in the region. Furthermore, the strong foothold of North America in genomics, proteomics, oncology, diagnostic screening, and drug discovery has significantly contributed to maintaining its large share. In the region, the United States is leading the market and is expected to continue the same over the forecast period.

Oligonucleotide Synthesis Market2

Competitive Landscape

The companies are seen adopting various strategies that include the acquisition of players in the emerging markets, distribution partnerships, and collaboration for the development of novel technologies. The companies operating in the oligonucleotide synthesis industry are also expanding and developing their product portfolios, which helps to drive the overall market.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Government Investments and R&D Expenditure in Pharmaceutical and Biotechnology Companies

      2. 4.2.2 The Use of Synthesized Oligonucleotides in Molecular Diagnostics and Clinical Applications

    3. 4.3 Market Restraints

      1. 4.3.1 High Treatment Cost of Oligonucleotides

      2. 4.3.2 Lack of Skilled Professionals and Research Support in Undeveloped Countries

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product Type

      1. 5.1.1 Synthesized Oligonucleotide Products

      2. 5.1.2 Reagents

      3. 5.1.3 Equipment

      4. 5.1.4 Services

    2. 5.2 By Application

      1. 5.2.1 Research

      2. 5.2.2 Diagnostics

      3. 5.2.3 Therapeutics

    3. 5.3 By End User

      1. 5.3.1 Academic Research Institutes

      2. 5.3.2 Pharmaceutical and Biotechnology Companies

      3. 5.3.3 Hospital and Diagnostic Laboratories

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Agilent Technologies

      2. 6.1.2 Thermo Fisher Scientific

      3. 6.1.3 Merck KGaA

      4. 6.1.4 Danaher Corporation

      5. 6.1.5 Bio-Synthesis Inc.

      6. 6.1.6 Eurofins Scientific

      7. 6.1.7 Kaneka Corporation (Eurogentec)

      8. 6.1.8 GenScript

      9. 6.1.9 LGC Limited (LGC Biosearch Technologies)

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Oligonucleotide Synthesis Market market is studied from 2018 - 2026.

The Oligonucleotide Synthesis Market is growing at a CAGR of 12.3% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Thermo Fisher Scientific, Agilent Technologies, Merck KGaA, Bio-Synthesis Inc, Eurofins Scientific are the major companies operating in Oligonucleotide Synthesis Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!